Indian marketer to promote gatifloxacinto pediatricians

Article

Irvine, CA-India-based Lupin Pharmaceuticals will promote gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) in the pediatric specialty area in the United States.

Recent Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Edward Manche, MD
Related Content
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children

Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children

Article
ROP: Treating and preventing blindness in preterm babies

ROP: Treating and preventing blindness in preterm babies

Podcast
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia

Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia

Article
Managing a changing landscape of IRD pediatric cases

Managing a changing landscape of IRD pediatric cases

Podcast
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management

Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management

Article
Bipartisan proposal introduced in US House to address children's vision impairment

Bipartisan proposal introduced in US House to address children's vision impairment

Article
© 2024 MJH Life Sciences

All rights reserved.